COVID 19 SENTINEL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

COVID 19 SENTINEL Trademark

Serial Number: 79301184 • Registration: 6624276

COVID 19 SENTINEL is a trademark filed by EUROFINS SCIENTIFIC (IRELAND) LIMITED on September 30, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EUROFINS SCIENTIFIC (IRELAND) LIMITED (44 trademarks)

Entity Type: 99

Trademark Details

Filing Date

September 30, 2020

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Medical testing services, namely, blood testing, saliva, urine, tissue, hair and body fluid testing services for diagnostic or treatment purposes; serological and urinary testing services for medical, epidemiological purposes; medical testing services in the field of epidemiology and genetics; DNA and RNA analyses for medical testing; DNA and RNA screening for medical testing purposes; viral screening for medical testing purposes; medical and health assessment services in connection with DNA and RNA; genetic testing for medical purposes; hospital services; medical assistance services and medical services in the field of epidemiology and genetics; medical clinic services; medical consultation services; medical consultation in the fields of genetics and epidemiology; maintaining patient medical record online; collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids for medical purposes; medical testing for diagnostic and epidemiological treatment purposes; medical testing for epidemiological diagnosis purposes; medical testing for diagnostic purposes in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of test panels in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of medical biology test panels and the interpretation of medical biology test results; providing bio-pathological medical information and advice relating to medical biology tests; medical testing for diagnostic and treatment purposes featuring testing for assessing immunogenicity, hypersensitivity and adverse immune stimulation; medical testing for diagnostic or treatment purposes in the field of infectious diseases; prenatal diagnostic testing for medical purposes

Scientific research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, and biochemistry; industrial research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; scientific research and development in the fields of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses, clinical and in-vitro studies in the feed, agro, chemical, cosmetic, personal care, agrochemical, biotechnology, aero-space, automobile, consumer products, semiconductor, electronics, energy, magnetic storage and any science-oriented industries and in environmental testing; carrying out scientific study and research in the fields of genetic analyses in the fields of plant and animal products; carrying out scientific study and research in the fields of genetic analyses in the feed, agro, chemical, cosmetic, personal care, biotechnology and consumer products industries; development of methods, namely, establishment and carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; scientific research, medical research and industrial engineering research resulting in expert reports for scientists and engineers; professional consultancy in the fields of scientific and medical research and research on medical treatments; DNA, RNA and virus analyses for scientific purposes; technical project studies; gene libraries, namely, collections of DNA and RNA fragments, variants or combination of genes for medical or veterinary use; scientific and technological services, namely, scientific research, scientific analysis, scientific research consulting, industrial design, engineering, scientific development and genetic laboratory testing services for research purposes for others in the field of genetics and epidemiology; scientific research featuring on-line data collection and provision, data interpretation, consultancy and advisory services related to feed testing services; database design and development; providing online information about industrial analysis and research services in the fields of environmental testing, genetics and epidemiology; providing scientific research information including scientific analysis data and results from an online searchable database; information technology services, namely, providing an online searchable database with algorithms in the field of scientific research analysis results based on genomics data; providing online information in the field of technological research relating to environmental testing, genetics and epidemiology from a computer database or the internet; new product development and research in the fields of biotech products, chemicals and agro-chemicals; scientific research services in the areas of genomics, proteomics, chemistry, biology, epidemiology medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; providing scientific information in the field of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data by using information technology tools and techniques; conducting clinical trials for others in the fields of cosmetics and personal care products; scientific research featuring the use of information technology tools and techniques to work with existing biological data and to generate information on the epidemiology, genomics and proteomics of living organs including human beings through research and study; scientific and technological services, namely, scientific and medical laboratory services, laboratory research and development in the fields of epidemiology, biomedicine and biobanking; consultation and analysis services for scientific research purposes in the fields of biotechnology, medical diagnostics and drug therapy; DNA and RNA analyses for scientific purposes; DNA and RNA screening for scientific purposes; viral screening for scientific purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 15, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 22, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Jul 5, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 5, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 25, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 17, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 17, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 12, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 11, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2021 DOCK
ASSIGNED TO EXAMINER
Mar 2, 2021 DOCK
ASSIGNED TO EXAMINER
Feb 25, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 8, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 31, 2020 REPR